{
    "2018-02-05": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Greek govt alleges official ties to drug bribery scandal",
                "features": {
                    "keywords": [
                        "Greek",
                        "govt",
                        "drug",
                        "bribery",
                        "scandal"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-03-15",
                "original_text": "3 Top Pharmaceuticals Stocks to Buy Now",
                "features": {
                    "keywords": [
                        "Top",
                        "Pharmaceuticals",
                        "Stocks",
                        "Buy"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-02-07",
                "original_text": "Novartis’s Valuations after Its 4Q17 Earnings",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Valuations",
                        "4Q17",
                        "Earnings"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-02-07",
                "original_text": "Novartis’s 4Q17 Earnings: Alcon Business",
                "features": {
                    "keywords": [
                        "Novartis",
                        "4Q17",
                        "Earnings",
                        "Alcon",
                        "Business"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-02-08",
                "original_text": "GSK Is Focused on Innovative Assets in Oncology Research Pipeline",
                "features": {
                    "keywords": [
                        "GSK",
                        "Innovative",
                        "Assets",
                        "Oncology",
                        "Research",
                        "Pipeline"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-02-07",
                "original_text": "Novartis’s 4Q17 Earnings: Sandoz Business",
                "features": {
                    "keywords": [
                        "Novartis",
                        "4Q17",
                        "Earnings",
                        "Sandoz",
                        "Business"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-02-08",
                "original_text": "How Biogen’s Biosimilars and Interferons Performed in 4Q17",
                "features": {
                    "keywords": [
                        "Biogen",
                        "Biosimilars",
                        "Interferons",
                        "4Q17"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-02-09",
                "original_text": "Multiple Myeloma May Be Strong Growth Area for GlaxoSmithKline",
                "features": {
                    "keywords": [
                        "Multiple",
                        "Myeloma",
                        "Growth",
                        "GlaxoSmithKline"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-02-10",
                "original_text": "The Swiss Stock Market Continues To Sell-Off",
                "features": {
                    "keywords": [
                        "Swiss",
                        "Stock",
                        "Market",
                        "Sell-Off"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}